News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cell Signaling Technology, Inc. Announces Renewal of PhosphoScan(R) Proteomics Research Project for Lead Compound Biomarker Discovery



11/11/2008 11:35:31 AM

DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST) announced today the renewal of a research agreement with Ortho-Biotech Oncology Research & Development (ORD), a Division of Janssen Pharmaceutica, N.V., under which CST will employ its patented PhosphoScan® and PTMScan™ technologies in research aimed at biomarker discovery and validation for multiple enzyme target classes and lead small-molecule inhibitors.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES